|
Volumn 23, Issue 15, 2015, Pages 4155-4162
|
Synthesis of new oxadiazole derivatives as α-glucosidase inhibitors
|
Author keywords
Antidiabetic; Benzohydrazone; Oxadiazole; Glucosidase inhibitors
|
Indexed keywords
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 FLUOROBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 HYDROXY 5 METHOXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 HYDROXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 METHOXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 METHYLBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2 NITROBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2,4,5 TRIHYDROXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (2,4,6 TRIHYDROXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (3 HYDROXY 4 METHYLBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (3 METHYLBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (3 NITROBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (4 HYDROXYBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (4 METHYLBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (4 NITROBENZYLIDENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (PYRIDIN 3 YLMETHYLENE)BENZOHYDRAZIDE;
4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL] N' (PYRIDIN 4 YLMETHYLENE)BENZOHYDRAZIDE;
ACARBOSE;
ALPHA GLUCOSIDASE INHIBITOR;
N' (2 CHLOROBENZYLIDENE) 4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL]BENZOHYDRAZIDE;
N' (2,5 DIHYDROXYBENZYLIDENE) 4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL]BENZOHYDRAZIDE;
N' (3,4 DIHYDROXYBENZYLIDENE) 4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL]BENZOHYDRAZIDE;
N' (4 CHLOROBENZYLIDENE) 4 [5 (2,4 DIMETHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL]BENZOHYDRAZIDE;
NEW DRUG;
OXADIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ALPHA GLUCOSIDASE;
GLYCOSIDASE INHIBITOR;
ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
IC50;
POLYMERIZATION;
STRUCTURE ACTIVITY RELATION;
SUBSTITUTION REACTION;
CHEMICAL STRUCTURE;
CHEMISTRY;
METABOLISM;
PRECLINICAL STUDY;
PROCEDURES;
SYNTHESIS;
ALPHA-GLUCOSIDASES;
CHEMISTRY TECHNIQUES, SYNTHETIC;
DRUG EVALUATION, PRECLINICAL;
GLYCOSIDE HYDROLASE INHIBITORS;
INHIBITORY CONCENTRATION 50;
MOLECULAR STRUCTURE;
OXADIAZOLES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84937512790
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2015.06.060 Document Type: Article |
Times cited : (81)
|
References (29)
|